Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Mersana Therapeutics Inc. (MRSN)

12.17 1.03 (9.25%)

09-18 16:00

Open:

11.28

Pre. Close:

11.14

High:

12.46

Low:

11.28

Volume:

485,913

Market Cap:

282M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

12.472 - 12.532

12.532 - 12.584

Low:

11.146 - 11.211

11.211 - 11.266

Close:

12.067 - 12.174

12.174 - 12.266

Technical analysis  (as of: 2018-09-18 4:38:04 PM)

Overall:

      

Stoxline posted a SELL today, upgraded from strong sell. But this stock still is very strong for short side. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell as long as the BUY warning is not issued.

Target:

Six months: 16.09     One year: 18.61

Support:

Support1: 10.30    Support2: 8.57

Resistance:

Resistance1: 13.78    Resistance2: 15.93

Pivot:

13.67

Moving Averages:

MA(5): 13.21     MA(20): 13.50

MA(100): 15.66     MA(250): 16.26

MACD:

MACD(12,26): -0.10     Signal(12,26,9): 0.07

%K %D:

%K(14,3): 43.93     %D(3): 60.50

RSI:

RSI(14): 41.39

52-Week:

High: 23.957  Low: 8.76  Change(%): -27.5

Average Vol(K):

3-Month: 19070  10-Days 23479

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
MRSN has closed above bottom band by 6.0%. Bollinger Bands are 34.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-09-17T12:45:02-04:00
Midday Gainers / Losers (09/17/2018)

2018-09-17T08:59:11-04:00
FDA lifts partial clinical hold on Mersana's XMT-1522; shares ahead 8% premarket

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology

Shares Out. (M)

23.15

Shares Float (M)

22.94

% Held by Insiders

% Held by Institutions

70.40

Shares Short (K)

2496

Shares Short Prior Month (K)

Stock Financials

EPS

-2.040

EPS Est. Current Year

-8.300

EPS Est. Next Year

-2.130

EPS Est. Next Quarter

Forward EPS

-2.360

Book Value (p.s.)

7.160

PEG Ratio

Profit Margin

Operating Margin

-285.20

Return on Assets (ttm)

-47.9

Return on Equity (ttm)

74.8

Qtrly Rev. Growth

12.4

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.338

Qtrly Earnings Growth

Operating Cash Flow (M)

-50.92

Levered Free Cash Flow (M)

-30.89

Valuation

P/E

-5.97

P/E Growth Ratio

0.09

P/BV

1.70

P/S

380723648.00

P/CF

-5.53

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.